Clinical Trial Detail

NCT ID NCT02342782
Title Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors City of Hope Medical Center
Indications

mature T-cell and NK-cell lymphoma

Therapies

Carmustine + Cytarabine + Etoposide + Melphalan + Yttrium Y 90 Basiliximab

Age Groups: adult

Additional content available in CKB BOOST